Your browser is no longer supported. Please, upgrade your browser.
Centogene N.V.
Index- P/E- EPS (ttm)-0.74 Insider Own32.69% Shs Outstand22.45M Perf Week-24.56%
Market Cap158.72M Forward P/E- EPS next Y-1.66 Insider Trans0.00% Shs Float9.18M Perf Month-28.02%
Income-17.30M PEG- EPS next Q-0.25 Inst Own51.90% Short Float0.65% Perf Quarter-31.31%
Sales254.00M P/S0.62 EPS this Y2.60% Inst Trans3.12% Short Ratio2.25 Perf Half Y-29.56%
Book/sh2.88 P/B2.40 EPS next Y-6.30% ROA-11.30% Target Price20.67 Perf Year-40.84%
Cash/sh1.72 P/C4.02 EPS next 5Y- ROE-24.80% 52W Range6.76 - 14.00 Perf YTD-35.90%
Dividend- P/FCF24.05 EPS past 5Y- ROI-22.30% 52W High-48.70% Beta-
Dividend %- Quick Ratio1.50 Sales past 5Y- Gross Margin26.80% 52W Low6.25% ATR0.56
Employees657 Current Ratio1.80 Sales Q/Q435.10% Oper. Margin-6.10% RSI (14)24.91 Volatility10.04% 5.74%
OptionableNo Debt/Eq0.42 EPS Q/Q31.50% Profit Margin-6.80% Rel Volume2.69 Prev Close6.91
ShortableYes LT Debt/Eq0.29 EarningsNov 24 BMO Payout- Avg Volume26.43K Price7.18
Recom1.20 SMA20-22.65% SMA50-26.76% SMA200-33.10% Volume32,491 Change3.94%
Aug-05-21Resumed Credit Suisse Outperform $14
Apr-24-20Downgrade Evercore ISI Outperform → In-line $21
Dec-03-19Initiated Robert W. Baird Outperform
Dec-02-19Initiated Evercore ISI Outperform
Dec-02-19Initiated BTIG Research Buy
Nov-24-21 08:55AM  
Nov-18-21 06:30AM  
Nov-04-21 06:30AM  
Oct-28-21 06:30AM  
Oct-19-21 07:20AM  
Oct-06-21 08:00AM  
Sep-30-21 07:05AM  
Sep-29-21 05:05PM  
Sep-07-21 04:00PM  
Sep-01-21 06:30AM  
Jul-27-21 06:30AM  
Jun-25-21 06:30AM  
Jun-22-21 06:30AM  
Jun-19-21 04:34AM  
Jun-16-21 08:00AM  
Jun-15-21 08:14AM  
Jun-09-21 04:30PM  
Jun-07-21 07:23AM  
Jun-04-21 10:07AM  
Jun-02-21 06:31AM  
Jun-01-21 06:30AM  
May-26-21 06:30AM  
May-18-21 06:30AM  
May-10-21 06:30AM  
May-07-21 06:32AM  
May-06-21 06:30AM  
May-05-21 06:30AM  
May-04-21 11:04AM  
May-03-21 11:50AM  
Apr-20-21 01:19AM  
Apr-19-21 03:12AM  
Apr-15-21 06:30AM  
Apr-14-21 06:30AM  
Apr-08-21 06:30AM  
Mar-09-21 06:30AM  
Feb-18-21 01:59AM  
Dec-18-20 10:02AM  
Dec-16-20 07:03AM  
Dec-09-20 06:30AM  
Dec-08-20 06:30AM  
Nov-25-20 06:30AM  
Nov-13-20 11:30AM  
Nov-09-20 04:00AM  
Nov-05-20 02:00AM  
Oct-20-20 08:17AM  
Oct-19-20 06:30AM  
Oct-14-20 08:14AM  
Sep-28-20 06:30AM  
Sep-25-20 06:32AM  
Sep-23-20 08:05AM  
Sep-16-20 08:30AM  
Sep-10-20 08:15AM  
Sep-03-20 06:30AM  
Sep-01-20 08:30AM  
Aug-20-20 01:30AM  
Aug-19-20 02:00AM  
Aug-11-20 06:30AM  
Aug-04-20 06:30AM  
Jul-27-20 08:00AM  
Jul-23-20 02:30AM  
Jul-09-20 07:19PM  
Jul-07-20 06:16PM  
Jul-06-20 06:30AM  
Jul-02-20 08:03AM  
Jul-01-20 10:22AM  
Jun-29-20 03:12PM  
Jun-28-20 09:41PM  
Jun-23-20 06:30AM  
Jun-15-20 06:30AM  
Jun-08-20 06:30AM  
Jun-04-20 11:00PM  
May-15-20 06:30AM  
May-12-20 01:16PM  
May-08-20 02:00PM  
May-06-20 06:30AM  
May-05-20 09:30AM  
Apr-23-20 06:30AM  
Apr-21-20 11:00AM  
Apr-17-20 06:30AM  
Apr-16-20 11:24AM  
Apr-15-20 09:29AM  
Mar-18-20 02:13PM  
Mar-17-20 03:39PM  
Mar-09-20 10:05AM  
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. The company develops rare disease platform, a data repository, which includes epidemiologic, phenotypic, and heterogenetic data that enhances methods for identifying and monitoring rare hereditary diseases and provide solutions that accelerate the development of orphan drugs. It provides various services, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. The company also offers COVID-19 testing solutions, including RT-PCR and antigen testing services. It has a strategic collaboration with Shire International GmbH and Pfizer Inc.; a collaboration agreement with Dr. Bauer Laboratoriums GmbH, Rostock by providing the medical laboratory services to perform its COVID-19 testing business activities; and a license agreement with Fraport AG to operate a test center for COVID-19 testing/diagnostics at Frankfurt Airport, Germany. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.